🔗 Share this article

An underground market for unapproved slimming medications is being driven by TikTok fitness influencers and sellers on communication apps, according to recent findings.

Investigational Drug Gaining Traction Via Social Media

The experimental drug, which is still in research studies, is being promoted by social media influencers for its supposed weight-reducing properties. Followers are encouraged to message these accounts privately for supplier links, while also receiving promotional offers.

Thriving Trade on Messaging Platforms

Separately, a robust market exists on Telegram, where groups with thousands of members share “before and after” photos, injection guides and claims of rapid UK delivery. Vendors promote the drug there before directing customers to WhatsApp for transactions.

Learning About The Experimental Drug

Retatrutide is an experimental injection developed by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could help individuals lose up to 25% of their body weight. Referred to as the “triple G”, the substance is being hailed digitally as the next Ozempic.

Medical Experts Express Concerns

Nevertheless, doctors and chemists have warned that the sale of what remains an unlicensed drug in the United Kingdom is worrisome and could lead to users injecting substances of unknown origin.

Some professionals stated the popularity for retatrutide could be connected to the increasing price of licensed slimming products such as Mounjaro.

Legal Position and Implementation

Marketing the unapproved drug on social media or messaging apps is illegal in the United Kingdom, as it is an unlicensed medication that cannot be marketed or distributed for human use under the British medical regulations.

Several influencers attempt to sidestep the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and supply can still breach pharmaceutical, marketing, and customer laws, potentially leading to fines, prosecution or prison.

Platform Reaction and Content Removal

Based on the social media company, the platform has taken down violative content and prohibited related keywords and query recommendations. The company stated it was dedicated to keeping the service safe and allocating resources in strengthening compliance measures.

Online Trading Activities

Investigations also discovered groups with up to 9,000 members marketing the experimental drug using the platform's integrated search feature, which functions like a public directory. Typing “retatrutide” immediately brings up channels with numerous of users, populated with images of weight loss, positive testimonials and step-by-step instructions for mixing or administering at residence.

After minutes of entering one group, a seller posted contact information, where most purchases take place. The seller sent an guidebook and guaranteed delivery within 48 hours. When questioned whether the product was genuine, one vendor responded: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. Not one inquired about body mass, health issues or previous experience.

Item Information and Pricing

Within these communities, posts display black plastic parcels with Royal Mail stickers, claiming to include new batches. One communication stated: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, prepared at home with purified liquid, or pre-filled pens typically sold at £160 for 20 milligrams. When asked how much time a pen should last, vendors give conflicting responses ranging from a several days to “depends on your body”.

Service Moderation and Safety Actions

A spokesperson for Telegram stated it regularly monitored dangerous content on its platform including material that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Cautions

“People are injecting substances they cannot confirm. Although the science behind retatrutide is sound, these online products may not contain what they claim,” stated a pharmacy expert, the director of pharmaceutical services at a pharmacy service.

A medical professional of Asda Online Doctor connected the increase in interest to recent price rises for approved weight-loss drugs such as Mounjaro. “With prices increasing, individuals are turning to online platforms. But fake treatments are extremely risky. You cannot know what’s inside or whether the conditions they were produced in was clean,” she said.

Her staff has already seen patients harmed by self-injection from unconfirmed sources. “We understand the frustration, but purchasing from Telegram or WhatsApp is taking chances with your well-being,” stated Wyllie. “These substances could be impure or incorrectly dosed.”

Producer Position

A representative from the pharmaceutical company said retatrutide was in phase 3 clinical trials and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Therefore at this point no one can sell [it] for human use,” they said, noting that any item “misleadingly claiming itself as a company experimental substance not yet authorized … may expose users to possibly serious medical dangers”.